Physical activity extends life of patients with peripheral artery diseaseJuly 06, 2006Patients with peripheral artery disease (PAD) who are physically active have death rates less than one third those in PAD patients who are inactive, according to research reported in the July issue of the journal Circulation. "We found that there is a survival benefit for patients with PAD who are more physically active in their daily routines," said Mary M. McDermott, M.D., senior author of the article and associate professor of medicine (general internal medicine) at Northwestern University Feinberg School of Medicine. Lower extremity PAD — a condition in which fatty deposits build up in the inner linings of artery walls in the legs — affects about 8 million Americans. PAD is associated with an increased risk for heart disease, heart attack and stroke.
Increasing age (55 years and older), smoking and diabetes are risk factors for PAD. Common symptoms are cramping and pain or tiredness in the leg or hip muscles while walking or climbing stairs. The pain usually goes away with rest. "Most patients with PAD are inactive to avoid the pain of cramps in their legs," McDermott said. But supervised treadmill walking is good for patients with PAD, who usually don't participate because of associated costs and time required for regular travel to and from a supervised exercise center, McDermott said. The study involved 460 men and women (average age 72 years) with PAD. Researchers assessed whether higher physical activity levels are associated with lower death rates in patients with PAD. At the beginning of the study, the investigators interviewed participants about their physical activity. Next, a vertical accelerometer measured the vertical movement of 225 participants over seven days. Participants wore the device like a pager, and it measured units of physical activities such as walking or climbing stairs. The researchers interviewed only the remaining 235 participants about their daily activity. After almost five years' follow-up, researchers concluded that participants with the lowest activity had a death rate more than three times higher than participants with the highest activity. They also had an increased risk for cardiovascular disease or death. Of the 460 participants with PAD, 134 died during the follow-up period. Forty percent of these deaths were due to cardiovascular disease. Participants who were ill at the beginning of the study were more likely to be both inactive and have a higher risk for death, so researchers repeated the analysis and excluded the participants who died during the first two years of follow-up. They found that physical activity was still associated with lower death rates. The study provides evidence that physicians should encourage patients with PAD to be more active and walk more. "It's observational data, so we still need to conduct a clinical trial," McDermott said. "Anything patients with PAD can do in their daily life to be more active may help them live longer. Simple tips to add more physical activity to a daily routine are parking farther away at the grocery store or taking the stairs," McDermott said. Northwestern University | |||||||||||||||||||||
|
Related Peripheral Artery Disease News Articles Limbs saved by menstrual blood stem cells Cells obtained from menstrual blood, termed 'endometrial regenerative cells' (ERCs) are capable of restoring blood flow in an animal model of advanced peripheral artery disease. Still puzzling: Best care for the frail and elderly with coronary artery disease A new study from Duke University Medical Center finds that patients treated solely with medications after suffering from chest pain, heart attack or coronary artery disease are more likely to die during the first year following their initial hospitalization. Brief, intense exercise benefits the heart Short bursts of high intensity sprints-known to benefit muscle and improve exercise performance-can improve the function and structure of blood vessels, in particular arteries that deliver blood to our muscles and heart, according to new research from McMaster University. In blood vessel stents, innovative materials allow better control, delivery of gene therapy Before gene therapy becomes practical for treating human diseases, researchers must master the details of safe and effective delivery. Many Stroke, Heart Attack Patients May Not Benefit from Aspirin Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown. Genetic mutation found in peripheral artery disease The finding, appearing online in the journal Circulation, is the first to document a genetic mutation linked to PAD. Although the work was done in mice, researchers say it is likely to give them new insight into how PAD develops and progresses in humans. Researchers discover new way to reverse poor circulation and heal wounds Researchers have solved a longstanding mystery about how flexing muscles "tell" nearby blood vessels that they need more blood to perform, according to a study published Feb. 15 in the journal Circulation Research. Global positioning tracker may better gauge severity of peripheral artery disease A space-based technology may provide an inexpensive and more reliable way to gauge the walking capacity in many patients with peripheral artery disease (PAD), whose clogged leg arteries cause them severe pain when they walk, according to a report in Circulation: Journal of the American Heart Association. A simplified scoring system may predict overall CVD risk, individual CVD components risk Physicians currently evaluate a patient's risk for heart disease, stroke and other cardiovascular diseases (CVD) individually, but a new assessment tool could gauge risk of overall ,or global, CVD and a range of cardiovascular diseases at one time, according to a study published in Circulation: Journal of the American Heart Association. Study looks at off-label use of biliary stents Although approved by the U.S. Food and Drug Administration as a palliative treatment for cancer patients who have developed bile-duct obstructions, biliary stents are sometimes used "off-label" for the treatment of peripheral vascular disease (PVD). More Peripheral Artery Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||